Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989–2023
Catherine R. Lesko(Johns Hopkins University), Richard Moore(Johns Hopkins University), Anthony T. Fojo(Johns Hopkins University), Geetanjali Chander(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), LaQuita N. Snow(National Institutes of Health), Jeanne Keruly(Johns Hopkins University), Joyce Jones(Johns Hopkins University), Y. Joseph Hwang(Johns Hopkins University), Lauren C. Zalla(Johns Hopkins University)
Cited by 6
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Nonfunctionalized Nanocrystals Can Exploit a Cell's Active Transport Machinery Delivering Them to Specific Nuclear and Cytoplasmic Compartments
|Nano Letters|2007|230
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
|Clinical Infectious Diseases|2013|206